Armenian commercial banks’ lending to processing industry shrinks 2.2% to AMD 169.1 billion in March

YEREVAN, May 12. /ARKA/. Armenia’s commercial banks lent AMD 169.1 billion to processing industry in March 2016 – 2.2% less than in February 2016, the Central Bank of Armenia says in a fresh issue of its monthly bulletin.

In March, loans were extended mostly in foreign currencies – 80.7% or the amount equal to 141.7 billion (2.2% decline).

Lending to processing industry in drams shrank 2.3% in March, compared with February, to AMD 27.4 billion.

Food segment dominated the banks’ aggregate lending to the processing industry in March with 31.6%. Loans extended to food producing companies in March totaled AMD 53.5 billion against AMD 54.3 billion in February.

As many as 20 registered commercial banks operate in Armenia now. ($1 – AMD 479.03). –0—

spot_img

POPULAR

Armenian dram weakened against the dollar and strengthened against the euro and ruble: Central Bank

The average market exchange rate for the US dollar to the Armenian dram, formed on the Armenian foreign exchange market as of August 24, 2026, increased by 0.22 points to 365.38 drams compared to August 21.

US dollar, euro, and ruble up against  Armenian dram

YEREVAN, August 20. /ARKA/. The average market exchange rate for the US dollar to the Armenian dram on the Armenian foreign exchange market as of August 20, 2026, increased by 0.3 points to 365.26 drams compared to August 19.

Armenia’s public debt will remain stable at just above 40% in the medium term – S&P

Armenia's public debt (excluding liquid assets) will remain broadly stable at just above 40% of GDP in the medium term, according to a report from the international rating agency S&P Global Ratings.

US dollar, euro, and ruble drop against Armenian dram

YEREVAN, August 18. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market as of August 18, 2026, fell by 0.25 points to 365.25 drams compared to August 17.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img